A detailed history of Great West Life Assurance CO transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Great West Life Assurance CO holds 7,565 shares of BPMC stock, worth $712,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,565
Previous 7,273 4.01%
Holding current value
$712,244
Previous $785,000 10.83%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$84.1 - $120.5 $24,557 - $35,186
292 Added 4.01%
7,565 $700,000
Q2 2024

Aug 12, 2024

BUY
$85.18 - $108.78 $37,394 - $47,754
439 Added 6.42%
7,273 $785,000
Q1 2024

May 13, 2024

BUY
$73.17 - $99.79 $18,731 - $25,546
256 Added 3.89%
6,834 $648,000
Q4 2023

Feb 13, 2024

SELL
$43.96 - $92.84 $577,238 - $1.22 Million
-13,131 Reduced 66.62%
6,578 $603,000
Q3 2023

Nov 14, 2023

BUY
$46.9 - $66.0 $180,752 - $254,364
3,854 Added 24.31%
19,709 $988,000
Q2 2023

Aug 10, 2023

BUY
$42.2 - $66.37 $46,124 - $72,542
1,093 Added 7.4%
15,855 $1.01 Million
Q1 2023

May 12, 2023

BUY
$37.97 - $50.0 $113 - $150
3 Added 0.02%
14,762 $665,000
Q4 2022

Feb 10, 2023

BUY
$41.06 - $66.48 $226,692 - $367,036
5,521 Added 59.76%
14,759 $650,000
Q3 2022

Nov 01, 2022

BUY
$49.93 - $77.7 $461,253 - $717,792
9,238 New
9,238 $608,000
Q2 2022

Aug 09, 2022

BUY
$45.23 - $70.15 $4,206 - $6,523
93 Added 3.13%
3,069 $155,000
Q1 2022

May 12, 2022

SELL
$54.1 - $110.08 $8,980 - $18,273
-166 Reduced 5.28%
2,976 $202,000
Q4 2021

Feb 14, 2022

BUY
$94.25 - $115.99 $8,199 - $10,091
87 Added 2.85%
3,142 $335,000
Q2 2021

Aug 11, 2021

SELL
$82.78 - $101.0 $22,102 - $26,967
-267 Reduced 8.04%
3,055 $269,000
Q1 2021

May 17, 2021

SELL
$90.71 - $108.28 $39,186 - $46,776
-432 Reduced 11.51%
3,322 $321,000
Q4 2020

Feb 16, 2021

BUY
$92.08 - $124.48 $42,264 - $57,136
459 Added 13.93%
3,754 $420,000
Q3 2020

Nov 17, 2020

SELL
$66.45 - $92.7 $106,652 - $148,783
-1,605 Reduced 32.76%
3,295 $305,000
Q3 2020

Nov 13, 2020

BUY
$66.45 - $92.7 $106,652 - $148,783
1,605 Added 48.71%
4,900 $454,000
Q4 2019

Feb 11, 2020

BUY
$66.73 - $82.59 $19,084 - $23,620
286 Added 9.5%
3,295 $263,000
Q3 2019

Oct 25, 2019

SELL
$72.9 - $101.41 $155,495 - $216,307
-2,133 Reduced 41.48%
3,009 $221,000
Q2 2019

Jul 31, 2019

SELL
$73.54 - $97.8 $58,611 - $77,946
-797 Reduced 13.42%
5,142 $0
Q1 2019

May 08, 2019

BUY
$48.7 - $86.6 $48,797 - $86,773
1,002 Added 20.3%
5,939 $474,000
Q1 2018

May 10, 2018

BUY
$73.28 - $102.95 $117,614 - $165,234
1,605 Added 48.17%
4,937 $453,000
Q3 2017

Nov 09, 2017

BUY
$42.37 - $69.67 $141,176 - $232,140
3,332
3,332 $228,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.62B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.